Xingjiang Hu

961 total citations
50 papers, 638 citations indexed

About

Xingjiang Hu is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Xingjiang Hu has authored 50 papers receiving a total of 638 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 15 papers in Oncology and 13 papers in Pharmacology. Recurrent topics in Xingjiang Hu's work include Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Research Studies (6 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). Xingjiang Hu is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Research Studies (6 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). Xingjiang Hu collaborates with scholars based in China, United Kingdom and Taiwan. Xingjiang Hu's co-authors include Yunliang Zheng, Jianzhong Shentu, Qiao Zhang, Nana Xu, Qingwei Zhao, Yunqing Qiu, Lihua Wu, Lingjuan He, Yan Lou and Kaijin Xu and has published in prestigious journals such as ACS Applied Materials & Interfaces, Annals of Oncology and Journal of Ethnopharmacology.

In The Last Decade

Xingjiang Hu

47 papers receiving 627 citations

Peers

Xingjiang Hu
Xingjiang Hu
Citations per year, relative to Xingjiang Hu Xingjiang Hu (= 1×) peers Mohsin Ali Khan

Countries citing papers authored by Xingjiang Hu

Since Specialization
Citations

This map shows the geographic impact of Xingjiang Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingjiang Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingjiang Hu more than expected).

Fields of papers citing papers by Xingjiang Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingjiang Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingjiang Hu. The network helps show where Xingjiang Hu may publish in the future.

Co-authorship network of co-authors of Xingjiang Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Xingjiang Hu. A scholar is included among the top collaborators of Xingjiang Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingjiang Hu. Xingjiang Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Li, Jichen, et al.. (2025). Cucurbitacin B alleviates DSS-induced ulcerative colitis by improving gut microbiota disorder in C57BL/6 mice. AMB Express. 15(1). 111–111. 1 indexed citations
5.
Li, Xiaodong, Xia Wu, Qi Wang, et al.. (2022). Sanguinarine ameliorates DSS induced ulcerative colitis by inhibiting NLRP3 inflammasome activation and modulating intestinal microbiota in C57BL/6 mice. Phytomedicine. 104. 154321–154321. 41 indexed citations
6.
Sun, Si, Chang Liu, Qiao Zhang, et al.. (2022). Efficacy and safety of immune checkpoint inhibitors in post-TKI NSCLC patients harboring EGFR mutations. Journal of Cancer Research and Clinical Oncology. 149(7). 2937–2949. 5 indexed citations
8.
Han, Songling, Wei Zhu, Weili Yang, et al.. (2021). A Prognostic Signature Constructed by CTHRC1 and LRFN4 in Stomach Adenocarcinoma. Frontiers in Genetics. 12. 646818–646818. 7 indexed citations
9.
Hu, Xingjiang, Hui Yu, Yunliang Zheng, et al.. (2020). Immune Checkpoint Inhibitors and Survival Outcomes in Brain Metastasis: A Time Series-Based Meta-Analysis. Frontiers in Oncology. 10. 564382–564382. 12 indexed citations
10.
Sun, Si, Zhihuang Hu, Shenglin Huang, et al.. (2019). REG4 is an indicator for KRAS mutant lung adenocarcinoma with TTF-1 low expression. Journal of Cancer Research and Clinical Oncology. 145(9). 2273–2283. 8 indexed citations
11.
12.
Zhang, Qiao, Yunliang Zheng, Xingjiang Hu, et al.. (2018). Ethnopharmacological uses, phytochemistry, biological activities, and therapeutic applications of Alpinia oxyphylla Miquel: A review. Journal of Ethnopharmacology. 224. 149–168. 90 indexed citations
13.
Zheng, Yunliang, Cong Cao, Meihua Lin, et al.. (2017). Identification and quantitative analysis of physalin D and its metabolites in rat urine and feces by liquid chromatography with triple quadrupole time‐of‐flight mass spectrometry. Journal of Separation Science. 40(11). 2355–2365. 6 indexed citations
14.
Chen, Junchun, Xingjiang Hu, Huili Zhou, et al.. (2017). Pharmacokinetic Properties of Three Forms of Vaginal Progesterone Administered in Either Single Or Multiple Dose Regimen in Healthy Post-menopausal Chinese Women. Frontiers in Pharmacology. 8. 212–212. 9 indexed citations
15.
Zhu, Wei, Wen Zheng, Xingjiang Hu, et al.. (2017). Variations of metabolites and proteome in Lonicera japonica Thunb. buds and flowers under UV radiation. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1865(4). 404–413. 12 indexed citations
16.
Zheng, Yunliang, Huili Zhou, Xingjiang Hu, et al.. (2015). Safety and pharmacokinetics of dicloxacillin in healthy Chinese volunteers following single and multiple oral doses. Drug Design Development and Therapy. 9. 5687–5687. 6 indexed citations
17.
Zheng, Yunliang, Xingjiang Hu, You Zhai, et al.. (2015). Pharmacokinetics and tissue distribution study of camellianin A and its major metabolite in rats by liquid chromatography with tandem mass spectrometry. Journal of Chromatography B. 997. 200–209. 6 indexed citations
20.
He, Qing, Xingjiang Hu, & Yiyu Cheng. (2006). Analysis of ‘SHUANGDAN’ granules by high-performance liquid chromatography–diode array detection–electrospray ionization tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 41(2). 485–492. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026